cisapride has been researched along with Nausea in 10 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of cisapride therapy in relieving symptoms of functional dyspepsia." | 9.08 | Efficacy of cisapride therapy in functional dyspepsia. ( Cowan, H; Eckstein, RP; Höschl, R; Kellow, JE; Lam, SK; Lunzer, MR; Riley, JW; Shuter, B, 1995) |
| "Cisapride and ranitidine improved the symptoms of diffuse epigastric pain, postprandial epigastric fullness, epigastric distension, belching, heartburn, regurgitation, and nausea when compared with baseline." | 9.08 | Cisapride compared with ranitidine in the treatment of functional dyspepsia. ( Carvalhinhos, A; Fidalgo, P; Freire, A; Matos, L, 1995) |
| "Low doses of cisapride (5-10 mg twice daily) produced relatively rapid relief from nausea elicited by venlafaxine in six patients with treatment-refractory recurrent major depression." | 9.08 | Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression. ( Russell, JL, 1996) |
| "To highlight a case of torsade de pointes ventricular arrhythmia induced by the concomitant use of cisapride and clarithromycin." | 7.70 | Torsade de pointes induced by cisapride/clarithromycin interaction. ( Piquette, RK, 1999) |
| "To assess the efficacy of cisapride therapy in relieving symptoms of functional dyspepsia." | 5.08 | Efficacy of cisapride therapy in functional dyspepsia. ( Cowan, H; Eckstein, RP; Höschl, R; Kellow, JE; Lam, SK; Lunzer, MR; Riley, JW; Shuter, B, 1995) |
| "Cisapride and ranitidine improved the symptoms of diffuse epigastric pain, postprandial epigastric fullness, epigastric distension, belching, heartburn, regurgitation, and nausea when compared with baseline." | 5.08 | Cisapride compared with ranitidine in the treatment of functional dyspepsia. ( Carvalhinhos, A; Fidalgo, P; Freire, A; Matos, L, 1995) |
| "Low doses of cisapride (5-10 mg twice daily) produced relatively rapid relief from nausea elicited by venlafaxine in six patients with treatment-refractory recurrent major depression." | 5.08 | Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression. ( Russell, JL, 1996) |
| "To highlight a case of torsade de pointes ventricular arrhythmia induced by the concomitant use of cisapride and clarithromycin." | 3.70 | Torsade de pointes induced by cisapride/clarithromycin interaction. ( Piquette, RK, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kellow, JE | 1 |
| Cowan, H | 1 |
| Shuter, B | 1 |
| Riley, JW | 1 |
| Lunzer, MR | 1 |
| Eckstein, RP | 1 |
| Höschl, R | 1 |
| Lam, SK | 1 |
| Carvalhinhos, A | 1 |
| Fidalgo, P | 1 |
| Freire, A | 1 |
| Matos, L | 1 |
| Bergeron, R | 1 |
| Blier, P | 1 |
| Güller, R | 1 |
| Reichlin, B | 1 |
| Jost, G | 1 |
| Russell, JL | 1 |
| Bohn, P | 1 |
| Sternbach, H | 1 |
| Amchin, J | 1 |
| Albano, D | 1 |
| Piquette, RK | 1 |
| Stacher, G | 1 |
| Gaupmann, G | 1 |
| Mittelbach, G | 1 |
| Schneider, C | 1 |
| Steinringer, H | 1 |
| Langer, B | 1 |
5 trials available for cisapride and Nausea
| Article | Year |
|---|---|
Efficacy of cisapride therapy in functional dyspepsia.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Dyspepsia; Eructation; Female; Gastric Emp | 1995 |
Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Topics: Adult; Antacids; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Dyspepsia; Eructation; Female; F | 1995 |
[Colonic preparation with sodium phosphate. Prospective, randomized, placebo-controlled double blind study with various antiemetics].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Cathartics; Cisapride | 1996 |
Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Drug | 1996 |
Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man.
Topics: Administration, Oral; Adult; Blood Pressure; Cisapride; Clinical Trials as Topic; Double-Blind Metho | 1987 |
5 other studies available for cisapride and Nausea
| Article | Year |
|---|---|
[With evidence-based phytotherapy. Takes away gastric and intestinal irritation].
Topics: Antiemetics; Cisapride; Clinical Trials as Topic; Dopamine Antagonists; Evidence-Based Medicine; Gas | 2003 |
Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors.
Topics: Adult; Cisapride; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Nausea; Pipe | 1994 |
Social phobia-related nausea relieved with adjunctive cisapride.
Topics: 1-Naphthylamine; Adolescent; Cisapride; Drug Therapy, Combination; Humans; Male; Nausea; Phobic Diso | 1997 |
Clinical considerations in managing nausea associated with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Gastrointes | 1997 |
Torsade de pointes induced by cisapride/clarithromycin interaction.
Topics: Aged; Anti-Bacterial Agents; Cisapride; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enz | 1999 |